Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,570,304
-$321,810 QoQ
Shares Held
65,212
-3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,074
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. PFE ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
This page
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,570,304 | 65,212 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,892,114 | 67,383 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,598,455 | 64,195 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,617,776 | 63,492 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,545,542 | 63,760 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,650,166 | 65,121 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,392,135 | 52,474 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,505,024 | 52,005 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,457,338 | 52,085 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,525,417 | 54,970 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,569,342 | 54,510 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,131,835 | 64,270 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,423,264 | 66,065 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,747,880 | 67,350 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,452,551 | 67,380 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,975,154 | 67,988 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,702,868 | 70,625 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,399,684 | 65,669 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,858,563 | 65,344 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,858,014 | 66,450 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,695,813 | 68,841 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,430,127 | 67,075 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,526,270 | 68,630 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,016,478 | 27,697 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,063,862 | 32,534 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,376,296 | 42,166 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||